David A. Edwards, a professor of Biomedical Engineering at Harvard, is set to launch a new product that he developed, this fall. He claims that the product reduces almost 100% of particles that are present in exhaled air. This will help reduce the transmission of SARS-CoV-2 both out of and into the lungs while breathing. This would mean that the risk of contracting COVID-19 would significantly decrease, especially for frontline workers, when it is used in combination with other Personal Protective Equipment like face masks.
The product is known as FEND and has been produced by Sensory Cloud, a tech startup owned by Edwards. FEND is a calcium chloride-based solution, almost like a saline spray and it contains no drugs, so no FDA approval is needed. Peer-reviewed research that was published in QRB Discovery by Sensory Cloud showed that the solution, when inhaled in mist form, cleaned the upper human airways…
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
